September 8, 2008
    Print this page +1    +2    +3      Standard Text
    Overview
    Signs & Symptoms
    Screening and diagnosis
    Treatments
    Clinical Trials
    People
    Bladder Cancer Research
    Center
    Screening and Detection
    New Drug Development
    & Treatment for superficial
    Bladder Cancer
    Surgical Innovation in
    Management of Invasive
    Bladder Cancer
    Exploring Treatment for
    Bladder Cancer
    Bladder Preserving Therapies
    Symptom Management
    and Quality of Life Issues
    Books/Articles
    Audio/Video Resources
    Related Links
    Meeting Tracker
   


SURGICAL INNOVATION IN MANAGEMENT OF INVASIVE BLADDER CANCER

"Nerve sparing" cystoprostatectomy
Neobladder bladder reconstruction

Surgical treatment of patients with genitourinary malignancies remains a paramount interest of the faculty and staff of the Brady Urological Institute; and that interest extends importantly to patients with all forms of bladder cancer.

Discoveries by Dr. Patrick C.Walsh defined the location of nerves that are responsible for potency in men. Years of surgical research and anatomic studies of the location of these nerves have allowed for the development of a highly emulated technique for "nerve sparing" removal in the male (complete cystoprostatectomy) to permit preservation of potency in patients undergoing major surgery for bladder cancer.

 







Neuroanatomical approach to radical cystoprostatectomy with preservation of sexual function.
J Urol. 1987 Dec;138(6):1402-6.

The disease-specific survival of men undergoing this types of surgery as well as data on potency after the operation appear below:


Local recurrence and survival following nerve sparing radical cystoprostatectomy for bladder cancer: 10-year followup.
J Urol. 1996 Feb; 155(2):490-4.


Post-operative potency status of 78 evaluable patients listed by pathological stage and age group at time of surgery (no.potent/no.evaluable)

Stage 20-29
years
30-39 40-49 50-59 60-69 70-79 Totals
PO - - 2/2 5/7 2/5 - 9/14      64%
PA - - 1/3 - - 1/3 2/6      33%
PIS - - 0/1 2/5 3/10 0/1 5/17      22%
P1 - - 2/3 1/4 2/6 - 5/13      30%
P2 - - 2/2 1/2 1/1 - 4/5      80%
P3A 1/1 - 1/2 1/1 0/1 0/1 2/5      40%
P3B - - 0/3 1/4 2/5 1/4 5/17      29%
P4 - - - 1/1 - - 1/1      100%
Totals 1/1
100%
- 8/16
50%
12/14
50%
11/31
35%
1/6
17%
 

The surgical intervention for invasive bladder cancer is routine and well organized at Johns Hopkins. Complete preoperative consultation, imaging, endoscopic evaluation and expert review of biopsy material and laboratory and x-ray data are accomplished by the faculty and staff of the Institute. All forms of urinary tract reconstruction including ileal-conduit, continent catheterizable and orthoptic neobladder reconstruction are routinely performed at Johns Hopkins.



© Copyright 2008 | All Rights Reserved | Disclaimer
Email: webmaster@urology.jhu.edu | 600 North Wolfe Street, Baltimore, Maryland 21287